Founders / Nardin Nakhla
Simmunome
AI disease simulation platform for drug target validation and patient biomarkers.
- Role
- Co-founder/CTO
- HQ
- Montréal, QC
- Founded
- 2016
- Status
- Active
- Disclosed raised
- C$2M
- Latest round
- Pre-seed, Sep 18, 2023
Co-founders: Armstrong Murira
Investors: Theodorus, Investissement Québec (Eurêka Fund), BKR Capital, Sandpiper Ventures, ACET Capital
Founders are listed as named in primary coverage of their companies. Profile links are matched to the company before they are published. To correct this page or ask for it to be removed, email the Index.
Data as of September 29, 2026.
